Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Akiko Takeshima"'
Autor:
Akiko Takeshima, Hiroaki Ogata, Yoshiyuki Kadokura, Yoshihiro Yamada, Kei Asakura, Tadashi Kato, Yoshinori Saito, Kantaro Matsuzaka, Go Takahashi, Masanori Kato, Masahiro Yamamoto, Hidetoshi Ito, Eriko Kinugasa
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-9 (2017)
Abstract Background Secondary hyperparathyroidism (SHPT) is associated with higher cardiovascular risk and mortality in patients undergoing dialysis. Cinacalcet hydrochloride (CH), which has been clinically available in Japan since 2008, could effect
Externí odkaz:
https://doaj.org/article/6ccb431de73841be812c02944df98e0c
Autor:
Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Akiko Takeshima, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida
Publikováno v:
Therapeutic Apheresis and Dialysis. 27:523-529
The clinical benefit of vitamin D receptor activators (VDRA) in patients with well-controlled secondary hyperparathyroidism undergoing dialysis remains unclear.This post hoc analysis of the LANDMARK study investigates if VDRA use is associated with c
Publikováno v:
Expert opinion on drug safety. 21(7)
Hyperphosphatemia is an inevitable complication for patients undergoing dialysis, as is the resulting need for treatment with phosphate binders. Currently, various phosphate binders are clinically available. In addition to their phosphate-lowering ac
Autor:
Hiroaki Ogata, Kantaro Matsuzaka, Akiko Takeshima, Hidetoshi Ito, Masahiro Yamamoto, Yoshiyuki Kadokura, Tadashi Kato, Yoshinori Saito, Kei Asakura, Go Takahashi, Eriko Kinugasa, Yoshihiro Yamada, Masanori Kato
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-9 (2017)
Background Secondary hyperparathyroidism (SHPT) is associated with higher cardiovascular risk and mortality in patients undergoing dialysis. Cinacalcet hydrochloride (CH), which has been clinically available in Japan since 2008, could effectively red
Autor:
Yutaka Nakajima, Kantaro Matsuzaka, Mikio Wakasa, Hiroaki Ogata, Kae Ito, Kanji Shishido, Akiko Takeshima, Chiaki Kumata
Publikováno v:
Therapeutic Apheresis and Dialysis. 18:19-23
Bixalomer (Bix) is an amine-functional polymer, non-calcium-containing phosphate (P) binder, and has been clinically available in Japan recently. Bix is expected to cause fewer gastrointestinal (GI) side-effects as compared with sevelamer hydrochlori
Autor:
Tomohiro Matsuhashi, Xiaoxiang Yan, Jin Endo, Weifeng Shen, Ken Shinmura, Yoshinori Katsumata, Kentaro Ito, Motoaki Sano, Akiko Takeshima, Tsunehisa Yamamoto, Atsushi Anzai, Keiichi Fukuda
Publikováno v:
Journal of Molecular and Cellular Cardiology. 62:24-35
Acute myocardial infarction (MI) causes sterile inflammation, which is characterized by recruitment and activation of innate and adaptive immune system cells. Here we delineate the temporal dynamics of immune cell accumulation following MI by flow cy
Publikováno v:
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. 28:453-456
Publikováno v:
YAKUGAKU ZASSHI. 124:693-697
Due to the evolvement of the aged society and the steep rise in medical costs, the environment encircling the medical care industry has been changing remarkably. For this reason, it has become both necessary and fundamental for a community pharmacist
Autor:
Kae, Ito, Akiko, Takeshima, Kanji, Shishido, Mikio, Wakasa, Chiaki, Kumata, Kantaro, Matsuzaka, Yutaka, Nakajima, Hiroaki, Ogata
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 18
Bixalomer (Bix) is an amine-functional polymer, non-calcium-containing phosphate (P) binder, and has been clinically available in Japan recently. Bix is expected to cause fewer gastrointestinal (GI) side-effects as compared with sevelamer hydrochlori
Autor:
Hiroaki Ogata, Yukihiro Wada, Akiko Takeshima, Noriyo Yoshida, Masahiro Yamamoto, Hidetoshi Ito, Eriko Kinugasa, Yui Takeshige
Publikováno v:
Clinical and Experimental Nephrology
Background Immunoglobulin (Ig) A nephropathy (IgAN) is characterized by mesangial deposits of IgA1 and C3, often with co-deposits of IgG. We attempted to clarify the clinical significance of mesangial IgG deposition in patients with IgAN. Methods We